Nucleic Acid Controls
Takara Bio HUM.WHOLE BRAIN/50UG
Human Brain Total RNA 50microgram for PCR cDNA synthesis and RT-PCR analysis
Seracare Life Sciences Inc ctDNA Mutation Mix v2 AF0.5%, 25 uL
To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations.
Seracare Life Sciences Inc ctDNA Mutation Mix v2 AF2%, 25 uL
To overcome the lack of patient-like reference materials for liquid biopsy, including drawbacks of existing methodologies such as sonication, SeraCare has developed a breakthrough technology that produces the most patient-like materials compared to native ctDNA. The Seraseq ctDNA Mutation Mix v2 is a highly multiplexed product for NGS-based ctDNA assays targeting cancer-relevant somatic mutations.
Abcam RNA Bisulfite Conversion Kit.
RNA Bisulfite Conversion Kit.
The product is subject to the following: Abcam Restricted Use Statement
Cayman Chemical RNA PolymRase I MoncLNal A
A σ receptor ligand with anticancer and antiviral activites binds to σ1 and σ2 receptors (Kis 13 and 0.28 nM respectively in MCF-7 cell membranes) selective for σ1 and σ2 receptors over hERG channels (Ki 1000 nM) inhibits growth of MCF-7 and multidrug-resistant MCF-7/adr cells (IC50s 25 and 15 nM respectively) decreases basal P-gp levels in the same cells reduces SARS-CoV-2 infectivity in Vero E6 cells (IC90 278 nM)
Seracare Life Sciences Inc Seraseq FFPE TMB RM Score 13 | 2 x 10 um
To improve and harmonize the measurement of TMB, Seracare Life Sciences has generated and characterized tumor-normal human cell lines with different TMB scores for whole exome sequencing analysis of TMB in patient samples, for validating targeted NGS panel-based TMB assays, and as controls for TMB measurements in I-O clinical trial projects.